Meet the team
Who We Are
New Equilibrium brings together interdisciplinary experts with the shared goal of drugging intrinsically disordered proteins.
Leadership Team
Virginia Burger, Ph.D.
Co–founder and CEO
Julian Levell, Ph.D.
Head of Discovery
Peter Tompa, Ph.D.
Co–founder and Chair of SABDiscovery Team
Charles DeLisle, Ph.D.
Senior Scientist, Biophysics
Hsiao-Yun Chen, Ph.D.
Senior Scientist, Biochemistry & Cell Biology
Chie Ueda, Ph.D.
Scientist I, Biomolecular SciencesPlatform Development Team
Lars Bratholm, Ph.D.
Principal Scientist, Machine Learning
Tao Jiang, Ph.D.
Senior Scientist, Computational Chemistry
Acadia Connor, B.A.
HPC Program Manager and Research Associate II, Computational Chemistry
Bentley Wingert, Ph.D.
Advanced Analytics Data Science InternBusiness Development Team
Hang Cao, B.F.A.
Communications Manager
Austin Alexander, B.S.
Operations ManagerScientific Advisory Board
Lila M. Gierasch, Ph.D.
Professor, Chemistry & Biochemistry and Molecular Biology, UMass Amherst
AJ Milici, Ph.D.
President, Milici Consulting LLC
Emir Roach, M.D.
Principal, Biopharma, Boston Consulting Group
Jianhan Chen, Ph.D.
Professor, Chemistry & Biochemistry and Molecular Biology, UMass Amherst
Olexandr Isayev, Ph.D.
Professor, Department of Chemistry, Carnegie Mellon University
Sally Wang Liang, J.D./M.P.H.
VP of Business Development, Head of Global Business Unit, PepLib
VK Gadi, M.D. PH.D.
Professor and Director, Medical Oncology, U of Illinois at Chicago
Keith Dunker, Ph.D.
Professor Emeritus of Biochemistry and Molecular Biology, Indiana University